Shares of Kenvue Inc. KVUE rose 2.90% to $23.39 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.13% to 5,282.70 and the ...

It’s now made with famotidine, the active ingredient in competitor Pepcid, which is marketed jointly by Merck & Co. and Johnson & Johnson spinoff Kenvue Inc. Wisner, who argued on behalf of ...

Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Tylenol®, Neutrogena® and Listerine®, today announced a five-year collaboration with Microsoft which aims to establish a strong ...

SUMMIT, N.J., April 16, 2025--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Tylenol®, Neutrogena® and Listerine®, today announced a five-year collaboration ...

Kenvue had a net margin of 6.66% and a return on equity of 20.97%. On average, equities analysts anticipate that Kenvue will post 1.14 EPS for the current fiscal year. Kenvue Announces Dividend ...

There have also been several standout performances. We've seen stars rise to the occasion, players lift their team up to a title and unexpected role players pop off for scoring outbursts in the ...

The Street Profits are nearly a month into their latest title reign after they defeated DIY on the March 14 edition of SmackDown. Since then, Angelo Dawkins and Montez Ford have racked up a win ...

With over two decades of global pharmaceutical and consumer health experience, James has held senior leadership roles at industry-leading companies including Johnson & Johnson, Kenvue ... He now holds ...